Benchmark Genetics anticipates that authorities will develop a constructive, regulatory system that permits the development and production of GE animals with improved health and welfare in the future. This will move towards the separate regulation of gene editing from conventional genetically modified organisms, which can involve transgenesis, or the transfer of DNA from one organism to another.
Benchmark Genetics does not use transgenesis or Gene Modification in its products. Please read our GMO statement
Benchmark Genetics’ overall focus is on sustainable breeding. This includes operating as an ethical and responsible company. The company sees GE as a tool for breeding livestock with improved health, animal welfare and performance. We research applications that do not pose a risk to the genetic integrity of the individual, the population or the environment. Research in functional genomics, where Benchmark Genetics is at the forefront of its industry, will identify genes that affect health and welfare as GE targets.
Acting responsibly as the guardians of our animals, we will consider implementing GE technology where it is socially and legally acceptable and when it can be demonstrated to improve the efficiency, health, and welfare of our animals.
In 2023, Benchmark Genetics, together with other aquaculture breeding companies in Norway, submitted a consultation response to the Norwegian Government’s White Paper NOU 2023:18 Gene Editing in a Sustainable Future. The response outlines our position on the potential use of gene editing technologies in aquaculture.. Read the consultation response.
Benchmark Genetics is an industry partner in several GE projects, including a project led by Nofima. This project aimed to apply the gene-editing tool CRISPR-Cas9 to assess why Pacific salmon species are less susceptible to sea lice than Atlantic salmon.
Read more about this project
